It has been determined that ACE2 was up-regulated in lung cancer patients, particularly in cases of lung adenocarcinoma and lung squamous cell carcinoma, and this upregulation is associated with reduced survival rates [33]. This evidence concerns the gene ACE2 and lung carcinoma.